世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

オピストルキア症治療の世界市場、タイプ別(薬物療法{抗生物質、駆虫薬、その他}v/s手術)、診断手順別(胆道造影、MRI、超音波検査、CTスキャン、その他)、症状別(黄疸、下痢、発熱、脾腫、体重減少、頻脈、その他)、エンドユーザー別(病院・クリニック、外来診療所、その他)、地域別、競争予測と機会、2017-2027年


Global Opisthorchiasis Treatment Market, By Type (Medications {Antibiotics, Anthelmintics, Others} v/s Surgery), By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others), By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast and Opportunities, 2017-2027

オピストホルキア症治療薬の世界市場は、予測期間中に大きな成長を遂げると予想されています。市場の成長は、世界人口の間で肝フクや猫フクによる感染症の発生率が上昇していることに起因していると考えられます... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年7月1日 US$4,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
110 英語

 

サマリー

オピストホルキア症治療薬の世界市場は、予測期間中に大きな成長を遂げると予想されています。市場の成長は、世界人口の間で肝フクや猫フクによる感染症の発生率が上昇していることに起因していると考えられます。味や栄養価の高さから魚介類の需要が高い一方、海産動物に見られるオピストホルキス・ビベルリニによる寄生虫感染症に関する認知度の低さが、オピストホルキア症治療薬の世界市場の成長を押し上げています。先進的な医薬品や外科的療法による疾患の早期診断と効果的な治療オプションのための研究開発活動の拡大。タイ、ベトナム、韓国、中国などのアジア諸国における長期の感染症への曝露と慢性疾患の蔓延が、オピストルキア症治療市場の世界的な成長を促進すると予想されます。地域住民の消毒ルールに関する知識が乏しく、素人漁師や密猟者の増加がオピストルキア症の発生率の上昇に寄与しており、オピストルキア症治療市場の世界的な成長を後押ししています。未処理の廃棄物ダンプによる海洋や水域の水源の汚染に起因する環境の枯渇に関する意識の高まりは、さらに海洋生物の感染症の上昇を助長し、世界人口の間で成長している肝臓感染症に寄与しています。世界中の人々が病気とその治療法についてますます認識するようになり、医療サービスや治療に対する需要は指数関数的に増加しています。さらに、医療施設の増加、新技術の出現、技術革新の高まりが、予測期間中の世界のオピストルキア症治療市場の成長に拍車をかけると予想されます。

眼瞼落下症治療の世界市場は、タイプ、診断手順、症状、エンドユーザー、地域分布、競争環境に基づいて区分されます。診断手順に基づいて、市場は胆管造影、MRI、超音波検査、CTスキャン、その他に分類されます。胆管造影は、便検査の標準化により、世界のオピストルキア症治療薬市場で最大のシェアを占めると予想されます。エンドユーザー別に見ると、市場は病院・診療所、外来診療所、その他に分類されます。病院・診療所分野は、より良い医療機器、製品、サービスを患者に提供することから、世界のオピストホルス症治療市場を支配すると予想されます。

オピストホルキア症治療の世界市場で事業を展開する主要企業には、Cipla Inc.、Johnson & Johnson、Sun Pharmaceutical Industries Ltd.、Merck KGaA、Boehringer Ingelheim International GmbH、Pfizer Inc.、GlaxoSmithKline plc、F. Hoffmann-La Roche Ltd、AbbVie Inc、Mankind Pharma Limited、その他の企業が含まれています。
本レポートで考慮した年数
歴史的年数:2017年〜2020年
基準年:2021年
推定年:2022E
予測期間:2023F-2027F
本調査の目的
- 2017年から2021年までの世界のオピストホルキア症治療薬市場の市場規模における歴史的成長を分析すること。
- 2022Eから2027Fまでの世界のオピストホルキア症治療薬市場規模および2027Fまでの成長率を推定・予測すること。
- タイプ、診断手順、症状、エンドユーザー、地域、競合環境に基づいて世界のオピストホルキア症治療市場を分類・予測する。
- オピストホルキア症治療薬の世界市場における支配的な地域やセグメントを特定する。
- 世界のオピストホルキア症治療市場の促進要因と課題を特定する。
- 世界のオピストホルキア症治療薬市場における拡張、新サービス、M&Aなどの競争的展開を検討する。
- 世界のオピストホルキア症治療薬市場で事業展開する主要企業のプロファイルを特定し、分析する。
- 世界のオピストホルキア症治療市場で市場プレーヤーが採用する主要な持続可能な戦略を特定する。
レポートの範囲
本レポートでは、オピストホルキア症治療の世界市場を、下記にも詳述している業界動向に加えて、以下のカテゴリーに分類しています。
- オピストホルキア症治療薬市場、タイプ別
o 薬物療法
抗生物質
駆虫薬
その他
o 外科手術
- オピストルキア症治療市場:診断手順別
o 胆道造影
o MRI
o 超音波検査
o CTスキャン
o その他
- オピストルキア症治療薬市場、症状別
o 黄疸
o 下痢
o 発熱
o 脾臓肥大
o 体重減少
o 頻脈
o その他
- オピストルキア症治療薬市場:エンドユーザー別
o 病院・診療所
o 外来診療所
o その他
- オピストホルキア症治療薬市場:地域別
o 北米
米国
メキシコ
カナダ
o ヨーロッパ
フランス
ドイツ
イギリス
イタリア
スペイン
o アジア太平洋地域
中国
インド
日本
韓国
オーストラリア
o 中東・アフリカ
南アフリカ共和国
サウジアラビア
UAE
o 南米
ブラジル
アルゼンチン
コロンビア

TechSci Researchは、この調査のために一次調査と徹底的な二次調査の両方を実施しました。まず、TechSci Research は世界中の企業のリストを入手しました。その後、TechSci Research は特定された企業に対して一次調査を実施しました。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかった企業も含めることができました。TechSci Research は、世界中のすべての主要なプレイヤーの企業および存在を分析しました。

TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来的な予測を行うボトムアップアプローチを用いて、世界のオピストルキア症治療市場の市場規模を算出しました。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの治療タイプの履歴データの分析を通じて外部で検証した。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。
主な対象読者
- オピストホルキア症治療サービスプロバイダ企業/パートナー
- エンドユーザー
- 規制当局や政策立案者などの政府機関
- 世界のオピストホルキア症治療市場に関連する組織、業界団体、フォーラム、アライアンス
本調査は、企業、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、投資戦略を立て、市場機会を活用する上で有用である。
競合の状況
企業プロフィール。世界のオピストホルキア症治療市場に存在する主要企業の詳細な分析。
利用可能なカスタマイズ。
TechSci Researchは与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です。
企業情報
- 追加市場プレイヤーの詳細分析およびプロファイリング(最大5社)。

ページTOPに戻る


目次

1. Service Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Opisthorchiasis Treatment Market
5. Voice of Customer
5.1. Prevalence, By Geography
5.2. Prevalence, By Gender
5.3. Commonly Observed Symptoms
5.4. Preferred Choice of Treatment
6. Global Opisthorchiasis Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Medications v/s Surgery)
6.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
6.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
6.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Opisthorchiasis Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Medications v/s Surgery)
7.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
7.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
7.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
7.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Opisthorchiasis Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Diagnostic Procedure
7.3.1.2.3. By Symptom
7.3.1.2.4. By End User
7.3.2. Mexico Opisthorchiasis Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Diagnostic Procedure
7.3.2.2.3. By Symptom
7.3.2.2.4. By End User
7.3.3. Canada Opisthorchiasis Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Diagnostic Procedure
7.3.3.2.3. By Symptom
7.3.3.2.4. By End User
8. Europe Opisthorchiasis Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Medications v/s Surgery)
8.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
8.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
8.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
8.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Opisthorchiasis Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Diagnostic Procedure
8.3.1.2.3. By Symptom
8.3.1.2.4. By End User
8.3.2. Germany Opisthorchiasis Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Diagnostic Procedure
8.3.2.2.3. By Symptom
8.3.2.2.4. By End User
8.3.3. United Kingdom Opisthorchiasis Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Diagnostic Procedure
8.3.3.2.3. By Symptom
8.3.3.2.4. By End User
8.3.4. Italy Opisthorchiasis Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Diagnostic Procedure
8.3.4.2.3. By Symptom
8.3.4.2.4. By End User
8.3.5. Spain Opisthorchiasis Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Diagnostic Procedure
8.3.5.2.3. By Symptom
8.3.5.2.4. By End User
9. Asia-Pacific Opisthorchiasis Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Medications v/s Surgery)
9.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
9.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
9.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
9.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Opisthorchiasis Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Diagnostic Procedure
9.3.1.2.3. By Symptom
9.3.1.2.4. By End User
9.3.2. India Opisthorchiasis Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Diagnostic Procedure
9.3.2.2.3. By Symptom
9.3.2.2.4. By End User
9.3.3. South Korea Opisthorchiasis Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Diagnostic Procedure
9.3.3.2.3. By Symptom
9.3.3.2.4. By End User
9.3.4. Japan Opisthorchiasis Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Diagnostic Procedure
9.3.4.2.3. By Symptom
9.3.4.2.4. By End User
9.3.5. Australia Opisthorchiasis Treatment Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Diagnostic Procedure
9.3.5.2.3. By Symptom
9.3.5.2.4. By End User
10. South America Opisthorchiasis Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Medications v/s Surgery)
10.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
10.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
10.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
10.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Opisthorchiasis Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Diagnostic Procedure
10.3.1.2.3. By Symptom
10.3.1.2.4. By End User
10.3.2. Argentina Opisthorchiasis Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Diagnostic Procedure
10.3.2.2.3. By Symptom
10.3.2.2.4. By End User
10.3.3. Colombia Opisthorchiasis Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Diagnostic Procedure
10.3.3.2.3. By Symptom
10.3.3.2.4. By End User
11. Middle East and Africa Opisthorchiasis Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type (Medications v/s Surgery)
11.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
11.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
11.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
11.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Opisthorchiasis Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Diagnostic Procedure
11.3.1.2.3. By Symptom
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Opisthorchiasis Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Diagnostic Procedure
11.3.2.2.3. By Symptom
11.3.2.2.4. By End User
11.3.3. UAE Opisthorchiasis Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Diagnostic Procedure
11.3.3.2.3. By Symptom
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Cipla Inc.
14.2. Johnson & Johnson
14.3. Sun Pharmaceutical Industries Ltd.
14.4. Merck KGaA
14.5. Boehringer Ingelheim International GmbH
14.6. Pfizer Inc.
14.7. GlaxoSmithKline plc
14.8. F. Hoffmann-La Roche Ltd
14.9. AbbVie Inc
14.10. Mankind Pharma Limited
15. Strategic Recommendations

 

ページTOPに戻る


 

Summary

The global opisthorchiasis treatment market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising incidences of infectious diseases caused by liver fluke and cat fluke among the global population. High demand for seafood due to their taste and nutritional value but lack of awareness about the parasitic infection caused by Opisthorchis Viverrini found in marine animals is boosting the growth of the global opisthorchiasis treatment market. Growing research and development activities for the early diagnosis and effective treatment options for diseases with advanced pharmaceutical products and surgical therapies. Prolonged infection exposure and the growing prevalence of chronic conditions in Asian countries like Thailand, Vietnam, Korea, and China are expected to fuel the growth of the global opisthorchiasis treatment market. Limited knowledge about the rules for disinfection of the local population and an increase in the number of amateur fishermen and poachers are contributing to the growing incidences of opisthorchiasis, which is propelling the growth of the global opisthorchiasis treatment market. Increasing awareness about the environmental depletion due to contamination of water sources in ocean and water bodies by untreated waste dump are further aiding to the rising infection in marine life, contributing to the growing liver infections among the global population. As people across the globe are increasingly becoming aware of the diseases and their available treatments, the demand for healthcare services and treatments is booming at an exponential rate. Moreover, the growing number of healthcare facilities, the emergence of new technologies, and rising innovation are expected to fuel the growth of the global opisthorchiasis treatment market during the forecast period.

The global opisthorchiasis treatment market is segmented on the basis on type, diagnostic procedure, symptom, end user, regional distribution, and competitive landscape. Based on diagnostic procedure, the market is divided into Cholangiography, MRI, Ultrasonography, CT scan, and others. The Cholangiography segment is expected to hold the largest share in the global opisthorchiasis treatment market due to the standardization of stool examination. Based on end-user, the market is fragmented into hospitals & clinics, ambulatory care centres, and others. The hospitals & clinics segment is anticipated to dominate the global opisthorchiasis treatment market as they provide better medical equipment, products, and services to the patients.

Major players operating in the global opisthorchiasis treatment market include Cipla Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Merck KGaA, Boehringer Ingelheim International GmbH, Pfizer Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., AbbVie Inc., Mankind Pharma Limited, among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F–2027F
Objective of the Study:
• To analyze the historical growth in the market size of global opisthorchiasis treatment market from 2017 to 2021.
• To estimate and forecast the market size of global opisthorchiasis treatment market from 2022E to 2027F and growth rate until 2027F.
• To classify and forecast global opisthorchiasis treatment market based on type, diagnostic procedure, symtom, end user, region, and competitive landscape.
• To identify dominant region or segment in the global opisthorchiasis treatment market.
• To identify drivers and challenges for global opisthorchiasis treatment market.
• To examine competitive developments such as expansions, new services, mergers & acquisitions, etc., in global opisthorchiasis treatment market.
• To identify and analyze the profile of leading players operating in global opisthorchiasis treatment market.
• To identify key sustainable strategies adopted by market players in global opisthorchiasis treatment market.
Report Scope:
In this report, global opisthorchiasis treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Opisthorchiasis Treatment Market, By Type:
o Medications
 Antibiotics
 Anthelmintics
 Others
o Surgery
• Opisthorchiasis Treatment Market, By Diagnostic Procedure:
o Cholangiography
o MRI
o Ultrasonography
o CT scan
o Others
• Opisthorchiasis Treatment Market, By Symptom:
o Jaundice
o Diarrhea
o Fever
o Splenomegaly
o Weight loss
o Tachycardia
o Others
• Opisthorchiasis Treatment Market, By End User:
o Hospitals & Clinics
o Ambulatory Care Centers
o Others
• Opisthorchiasis Treatment Market, By Region:
o North America
 United States
 Mexico
 Canada
o Europe
 France
 Germany
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 India
 Japan
 South Korea
 Australia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
o South America
 Brazil
 Argentina
 Colombia

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the companies and presence of all major players across the globe.

TechSci Research calculated the market size of the global opisthorchiasis treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these treatment types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Opisthorchiasis treatment service provider companies/partners
• End-Users
• Government bodies such as regulating authorities and policy makers
• Organizations, industry associations, forums and alliances related to global opisthorchiasis treatment market
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global opisthorchiasis treatment market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Service Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Opisthorchiasis Treatment Market
5. Voice of Customer
5.1. Prevalence, By Geography
5.2. Prevalence, By Gender
5.3. Commonly Observed Symptoms
5.4. Preferred Choice of Treatment
6. Global Opisthorchiasis Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Medications v/s Surgery)
6.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
6.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
6.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Opisthorchiasis Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Medications v/s Surgery)
7.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
7.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
7.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
7.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Opisthorchiasis Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Diagnostic Procedure
7.3.1.2.3. By Symptom
7.3.1.2.4. By End User
7.3.2. Mexico Opisthorchiasis Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Diagnostic Procedure
7.3.2.2.3. By Symptom
7.3.2.2.4. By End User
7.3.3. Canada Opisthorchiasis Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Diagnostic Procedure
7.3.3.2.3. By Symptom
7.3.3.2.4. By End User
8. Europe Opisthorchiasis Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Medications v/s Surgery)
8.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
8.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
8.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
8.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Opisthorchiasis Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Diagnostic Procedure
8.3.1.2.3. By Symptom
8.3.1.2.4. By End User
8.3.2. Germany Opisthorchiasis Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Diagnostic Procedure
8.3.2.2.3. By Symptom
8.3.2.2.4. By End User
8.3.3. United Kingdom Opisthorchiasis Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Diagnostic Procedure
8.3.3.2.3. By Symptom
8.3.3.2.4. By End User
8.3.4. Italy Opisthorchiasis Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Diagnostic Procedure
8.3.4.2.3. By Symptom
8.3.4.2.4. By End User
8.3.5. Spain Opisthorchiasis Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Diagnostic Procedure
8.3.5.2.3. By Symptom
8.3.5.2.4. By End User
9. Asia-Pacific Opisthorchiasis Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Medications v/s Surgery)
9.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
9.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
9.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
9.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Opisthorchiasis Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Diagnostic Procedure
9.3.1.2.3. By Symptom
9.3.1.2.4. By End User
9.3.2. India Opisthorchiasis Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Diagnostic Procedure
9.3.2.2.3. By Symptom
9.3.2.2.4. By End User
9.3.3. South Korea Opisthorchiasis Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Diagnostic Procedure
9.3.3.2.3. By Symptom
9.3.3.2.4. By End User
9.3.4. Japan Opisthorchiasis Treatment Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Diagnostic Procedure
9.3.4.2.3. By Symptom
9.3.4.2.4. By End User
9.3.5. Australia Opisthorchiasis Treatment Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Diagnostic Procedure
9.3.5.2.3. By Symptom
9.3.5.2.4. By End User
10. South America Opisthorchiasis Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Medications v/s Surgery)
10.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
10.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
10.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
10.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Opisthorchiasis Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Diagnostic Procedure
10.3.1.2.3. By Symptom
10.3.1.2.4. By End User
10.3.2. Argentina Opisthorchiasis Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Diagnostic Procedure
10.3.2.2.3. By Symptom
10.3.2.2.4. By End User
10.3.3. Colombia Opisthorchiasis Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Diagnostic Procedure
10.3.3.2.3. By Symptom
10.3.3.2.4. By End User
11. Middle East and Africa Opisthorchiasis Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type (Medications v/s Surgery)
11.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
11.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
11.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
11.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Opisthorchiasis Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Diagnostic Procedure
11.3.1.2.3. By Symptom
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Opisthorchiasis Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Diagnostic Procedure
11.3.2.2.3. By Symptom
11.3.2.2.4. By End User
11.3.3. UAE Opisthorchiasis Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Diagnostic Procedure
11.3.3.2.3. By Symptom
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Cipla Inc.
14.2. Johnson & Johnson
14.3. Sun Pharmaceutical Industries Ltd.
14.4. Merck KGaA
14.5. Boehringer Ingelheim International GmbH
14.6. Pfizer Inc.
14.7. GlaxoSmithKline plc
14.8. F. Hoffmann-La Roche Ltd
14.9. AbbVie Inc
14.10. Mankind Pharma Limited
15. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(アレルギー用薬)の最新刊レポート

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(antibiotics)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/07 10:27

155.63 円

167.26 円

203.27 円

ページTOPに戻る